Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-09-12 | Inhibrx Biosciences, Inc. | Lappe Mark
(Chief Executive Officer) |
P | Common Stock | A | 40000 | $15.05 - $17.13 | $629,116 |
| 2024-09-10 | Inhibrx Biosciences, Inc. | Vuori Kristiina MD
(Director) |
P | Common Stock | A | 6636 | $15.00 - $15.07 | $99,991 |
| 2024-08-28 | Inhibrx Biosciences, Inc. | MANHARD KIMBERLY
(Director) |
P | Common Stock | A | 10000 | $13.98 - $13.98 | $139,800 |
| 2024-06-24 | Inhibrx Biosciences, Inc. | Kayyem Jon Faiz
(Director) |
G | Common Stock | D | 109050 | $0.00 - $0.00 | $0 |
| 2024-06-05 | Inhibrx Biosciences, Inc. | Kayyem Jon Faiz
(Director) |
P | Common Stock | A | 57549 | $17.23 - $17.89 | $997,023 |
| 2024-05-31 | Inhibrx Biosciences, Inc. | Kayyem Jon Faiz
(Director) |
P | Common Stock | A | 286786 | $16.14 - $18.24 | $4,927,579 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |